These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28249601)

  • 1. A novel FOXO1-mediated dedifferentiation blocking role for DKK3 in adrenocortical carcinogenesis.
    Cheng JY; Brown TC; Murtha TD; Stenman A; Juhlin CC; Larsson C; Healy JM; Prasad ML; Knoefel WT; Krieg A; Scholl UI; Korah R; Carling T
    BMC Cancer; 2017 Mar; 17(1):164. PubMed ID: 28249601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of Forkhead Box Protein O1 (FOXO1) Transcription Factor May Promote Adrenocortical Tumorigenesis.
    Stenman A; Murtha T; Korah R; Carling T
    Horm Metab Res; 2017 Aug; 49(8):631-637. PubMed ID: 28641336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic silencing of RASSF1A deregulates cytoskeleton and promotes malignant behavior of adrenocortical carcinoma.
    Korah R; Healy JM; Kunstman JW; Fonseca AL; Ameri AH; Prasad ML; Carling T
    Mol Cancer; 2013 Aug; 12():87. PubMed ID: 23915220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLC12A7 alters adrenocortical carcinoma cell adhesion properties to promote an aggressive invasive behavior.
    Brown TC; Murtha TD; Rubinstein JC; Korah R; Carling T
    Cell Commun Signal; 2018 Jun; 16(1):27. PubMed ID: 29884238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCL9 Upregulation in Adrenocortical Carcinoma: A Novel Wnt/β-Catenin Activating Event Driving Adrenocortical Malignancy.
    Brown TC; Nicolson NG; Korah R; Carling T
    J Am Coll Surg; 2018 Jun; 226(6):988-995. PubMed ID: 29428231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephroblastoma overexpressed/cysteine-rich protein 61/connective tissue growth factor/nephroblastoma overexpressed gene-3 (NOV/CCN3), a selective adrenocortical cell proapoptotic factor, is down-regulated in childhood adrenocortical tumors.
    Doghman M; Arhatte M; Thibout H; Rodrigues G; De Moura J; Grosso S; West AN; Laurent M; Mas JC; Bongain A; Zambetti GP; Figueiredo BC; Auberger P; Martinerie C; Lalli E
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3253-60. PubMed ID: 17566092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic silencing of the WNT antagonist Dickkopf 3 disrupts normal Wnt/β-catenin signalling and apoptosis regulation in breast cancer cells.
    Xiang T; Li L; Yin X; Zhong L; Peng W; Qiu Z; Ren G; Tao Q
    J Cell Mol Med; 2013 Oct; 17(10):1236-46. PubMed ID: 23890219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of N-cadherin/β-catenin expression in adrenocortical tumors.
    Rubin B; Regazzo D; Redaelli M; Mucignat C; Citton M; Iacobone M; Scaroni C; Betterle C; Mantero F; Fassina A; Pezzani R; Boscaro M
    Tumour Biol; 2016 Oct; 37(10):13545-13555. PubMed ID: 27468715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of differential gene expression in adrenocortical tumors harboring beta-catenin (CTNNB1) mutations.
    Durand J; Lampron A; Mazzuco TL; Chapman A; Bourdeau I
    J Clin Endocrinol Metab; 2011 Jul; 96(7):E1206-11. PubMed ID: 21565795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dickkopf3 overexpression inhibits pancreatic cancer cell growth in vitro.
    Gu YM; Ma YH; Zhao WG; Chen J
    World J Gastroenterol; 2011 Sep; 17(33):3810-7. PubMed ID: 21987623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-Like Growth Factor and SLC12A7 Dysregulation: A Novel Signaling Hallmark of Non-Functional Adrenocortical Carcinoma.
    Brown TC; Nicolson NG; Stenman A; Juhlin CC; Gibson CE; Callender GG; Korah R; Carling T
    J Am Coll Surg; 2019 Sep; 229(3):305-315. PubMed ID: 31034883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of β-catenin in adrenocortical cancer cells causes growth inhibition and reversal of epithelial-to-mesenchymal transition.
    Salomon A; Keramidas M; Maisin C; Thomas M
    Oncotarget; 2015 May; 6(13):11421-33. PubMed ID: 25823656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancer.
    Dellinger TH; Planutis K; Jandial DD; Eskander RN; Martinez ME; Zi X; Monk BJ; Holcombe RF
    Gynecol Oncol; 2012 Aug; 126(2):259-67. PubMed ID: 22555103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors.
    Gaujoux S; Tissier F; Groussin L; Libé R; Ragazzon B; Launay P; Audebourg A; Dousset B; Bertagna X; Bertherat J
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4135-40. PubMed ID: 18647815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein arginine methyltransferase 5 (PRMT5) activates WNT/β-catenin signalling in breast cancer cells via epigenetic silencing of DKK1 and DKK3.
    Shailesh H; Siveen KS; Sif S
    J Cell Mol Med; 2021 Feb; 25(3):1583-1600. PubMed ID: 33462997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DKK3 is a potential tumor suppressor gene in papillary thyroid carcinoma.
    Yin DT; Wu W; Li M; Wang QE; Li H; Wang Y; Tang Y; Xing M
    Endocr Relat Cancer; 2013 Aug; 20(4):507-14. PubMed ID: 23702469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch1 pathway in adrenocortical carcinomas: correlations with clinical outcome.
    Ronchi CL; Sbiera S; Altieri B; Steinhauer S; Wild V; Bekteshi M; Kroiss M; Fassnacht M; Allolio B
    Endocr Relat Cancer; 2015 Aug; 22(4):531-43. PubMed ID: 25979380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dkk3, downregulated in cervical cancer, functions as a negative regulator of beta-catenin.
    Lee EJ; Jo M; Rho SB; Park K; Yoo YN; Park J; Chae M; Zhang W; Lee JH
    Int J Cancer; 2009 Jan; 124(2):287-97. PubMed ID: 19003969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.
    Tissier F; Cavard C; Groussin L; Perlemoine K; Fumey G; Hagneré AM; René-Corail F; Jullian E; Gicquel C; Bertagna X; Vacher-Lavenu MC; Perret C; Bertherat J
    Cancer Res; 2005 Sep; 65(17):7622-7. PubMed ID: 16140927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.